2024 Taiwan clinical practice guideline for diabetic kidney disease - an executive summary.

IF 2.5 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

Journal of the Formosan Medical Association Pub Date : 2025-08-20 DOI:10.1016/j.jfma.2025.08.020

Sheng-Chiang Su, Tieng-Chun Chang, Yi-Wen Chiu, Chih-Hsun Chu, Yueh-Han Hsu, Chin-Sung Kuo, Chun-Chuan Lee, Ming-Hsun Lin, Chun-Liang Lin, Yuh-Feng Lin, Da-Wei Lin, Hui-Yu Peng, Shwu-Pyng Su, Yi-Chun Tsai, Yao-Hsien Tseng, Jun-Sing Wang, Tsai-Jung Wang, Yi-Sun Yang, Chien-Ning Huang, Horng-Yih Ou, Mai-Szu Wu

{"title":"2024 Taiwan clinical practice guideline for diabetic kidney disease - an executive summary.","authors":"Sheng-Chiang Su, Tieng-Chun Chang, Yi-Wen Chiu, Chih-Hsun Chu, Yueh-Han Hsu, Chin-Sung Kuo, Chun-Chuan Lee, Ming-Hsun Lin, Chun-Liang Lin, Yuh-Feng Lin, Da-Wei Lin, Hui-Yu Peng, Shwu-Pyng Su, Yi-Chun Tsai, Yao-Hsien Tseng, Jun-Sing Wang, Tsai-Jung Wang, Yi-Sun Yang, Chien-Ning Huang, Horng-Yih Ou, Mai-Szu Wu","doi":"10.1016/j.jfma.2025.08.020","DOIUrl":null,"url":null,"abstract":"<p><p>Scientific advances and development in the management of diabetes including use of new glucose-lowering agents for cardiorenal protection in diabetic patients prompted revision of local clinical practice guideline for diabetic kidney disease (DKD). Multiple cross-disciplinary professional meetings were held in 2023 and 2024 by experts from the Diabetes Association of the Republic of China (Taiwan), the Taiwanese Association of Diabetes Educators and the Taiwan Society of Nephrology to review the latest evidence and to develop updated recommendations, taking local epidemiology, circumstances and relevant local guidelines into considerations. From screening and diagnosis; risk classification and monitoring; lifestyle modifications; glycemic, blood pressure and lipid management; to the use of cardiorenal protective medications and complication management, the 2024 Taiwan Clinical Practice Guideline for DKD aims to offer up-to-date reference and comprehensive guidance to local practitioners for optimization of DKD patient care.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Formosan Medical Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jfma.2025.08.020","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Scientific advances and development in the management of diabetes including use of new glucose-lowering agents for cardiorenal protection in diabetic patients prompted revision of local clinical practice guideline for diabetic kidney disease (DKD). Multiple cross-disciplinary professional meetings were held in 2023 and 2024 by experts from the Diabetes Association of the Republic of China (Taiwan), the Taiwanese Association of Diabetes Educators and the Taiwan Society of Nephrology to review the latest evidence and to develop updated recommendations, taking local epidemiology, circumstances and relevant local guidelines into considerations. From screening and diagnosis; risk classification and monitoring; lifestyle modifications; glycemic, blood pressure and lipid management; to the use of cardiorenal protective medications and complication management, the 2024 Taiwan Clinical Practice Guideline for DKD aims to offer up-to-date reference and comprehensive guidance to local practitioners for optimization of DKD patient care.

查看原文本刊更多论文

2024台湾糖尿病肾病临床实践指南-执行摘要。

糖尿病管理的科学进步和发展，包括使用新的降血糖药物对糖尿病患者的心肾保护，促使了当地糖尿病肾病临床实践指南（DKD）的修订。从筛查和诊断；风险分类与监测；生活方式的修改;血糖、血压和血脂管理；到心肾保护药物的使用和并发症的管理，2024台湾DKD临床实践指南旨在为当地医生提供最新的参考和全面的指导，以优化DKD患者的护理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the Formosan Medical Association 医学-医学：内科

CiteScore

6.50

自引率

6.20%

发文量

381

审稿时长

57 days

期刊介绍： Journal of the Formosan Medical Association (JFMA), published continuously since 1902, is an open access international general medical journal of the Formosan Medical Association based in Taipei, Taiwan. It is indexed in Current Contents/ Clinical Medicine, Medline, ciSearch, CAB Abstracts, Embase, SIIC Data Bases, Research Alert, BIOSIS, Biological Abstracts, Scopus and ScienceDirect. As a general medical journal, research related to clinical practice and research in all fields of medicine and related disciplines are considered for publication. Article types considered include perspectives, reviews, original papers, case reports, brief communications, correspondence and letters to the editor.